Valuation: BioElectronics Corporation

Market Cap 12.35M 10.6M 9.89M 9.08M 17.07M 1.18B 17.35M 117M 45.72M 592M 46.38M 45.37M 1.96B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 22.04M 20.58M 18.88M 35.51M 2.46B 36.09M 243M 95.09M 1.23B 96.48M 94.38M 4.07B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week+33.33%
Current month+33.33%
1 month+60.00%
3 months+6.95%
6 months+60.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 2019-11-14
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 2019-11-14
Chairman 85 2020-06-14
Director/Board Member - 2024-12-02
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+33.33%+100.00%-20.00% 4.94M
+3.05%+5.87%+27.49%+18.52% 227B
+3.84%+7.76%+3.94%-12.17% 149B
-1.17%-2.35%-18.44%+36.69% 141B
-2.98%-2.45%-52.45%+0.01% 75.37B
-0.87%-1.29%+12.26%+19.70% 53.19B
-0.26%+2.25%-17.11%-12.23% 51.88B
+2.28%+6.12%+33.01%+33.29% 43.89B
+0.95%+1.35%+41.24%+56.86% 40.86B
+0.88%+1.78%+1.67%+8.89% 33.7B
Average +0.58%+1.24%+13.16%+12.96% 81.49B
Weighted average by Cap. +1.22%+1.31%+3.97%+14.78%

Financials

2020 2021
Net sales 830K 712K 664K 610K 1.15M 79.29M 1.17M 7.84M 3.07M 39.77M 3.11M 3.05M 131M 1.61M 1.38M 1.29M 1.18M 2.22M 154M 2.26M 15.21M 5.96M 77.15M 6.04M 5.91M 255M
Net income -1.16M -995K -929K -852K -1.6M -111M -1.63M -10.96M -4.29M -55.59M -4.35M -4.26M -184M -290K -249K -232K -213K -401K -27.7M -407K -2.74M -1.07M -13.89M -1.09M -1.06M -45.94M
Net Debt 13.07M 11.21M 10.47M 9.6M 18.06M 1.25B 18.36M 124M 48.36M 626M 49.07M 48M 2.07B 13.34M 11.44M 10.69M 9.8M 18.44M 1.28B 18.74M 126M 49.38M 640M 50.1M 49.01M 2.11B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
26-08-19 US$0.000200 -33.33% 10,833,750
26-08-18 US$0.000300 -.--% 1,755,250
26-08-17 US$0.000300 -.--% 11,130,500
26-08-14 US$0.000300 -.--% 5,949,996
26-08-13 US$0.000300 -.--% 20,288,333
  1. Stock Market
  2. Stocks
  3. BIEL Stock